Patents by Inventor Glenn Nardone

Glenn Nardone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11529312
    Abstract: Embodiments of the present disclosure include anti-inflammatory compositions and methods of use thereof. The compositions include purified lipids from Francisella, for example, virulent strains of Francisella. Other features and advantages of the invention will be apparent from the detailed description, and from the claims.
    Type: Grant
    Filed: April 6, 2017
    Date of Patent: December 20, 2022
    Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Catharine Mans Bosio, Robin M. Ireland, Glenn A. Nardone
  • Publication number: 20190091151
    Abstract: Embodiments of the present disclosure include anti-inflammatory compositions and methods of use thereof. The compositions include purified lipids from Francisella, for example, virulent strains of Francisella. Other features and advantages of the invention will be apparent from the detailed description, and from the claims.
    Type: Application
    Filed: April 6, 2017
    Publication date: March 28, 2019
    Applicant: The U.S.A., as represented by the Secretary, Department of Health and Human Services
    Inventors: Catharine Mans Bosio, Robin M. Ireland, Glenn A. Nardone
  • Patent number: 6768000
    Abstract: An oligonucleotide, labeled with a molecular energy transfer trio and containing two sequences capable of hairpin formation, is used in the detection of two targets by irradiation with a single wavelength of light. One of the two sequences contains an energy donor and a first energy acceptor, and the other sequence contains a second energy acceptor. The donor is in close proximity to the second acceptor only if the hairpin is formed, while the donor is always in close proximity to first acceptor. A sample is assayed, using this oligonucleotide in conjunction with another oligonucleotide which contains the donor fluorophore and the quencher, arranged as described above, but which lacks the acceptor fluorophore. The present oligonucleotide and the other oligonucleotide are specific to first and second targets, respectively.
    Type: Grant
    Filed: January 17, 2001
    Date of Patent: July 27, 2004
    Assignee: Intergen Company
    Inventor: Glenn Nardone
  • Patent number: 6531581
    Abstract: Compounds are described comprising purines substituted at the C-8 position and pyrimidines substituted at the C-4 position with a linker and quencher. These compounds, when incorporated into hairpin oligonucleotides quench the fluorescence of fluorophores linked to the 5′-terminus of the oligonucleotide. These nucleotide-quencher compounds are also easily incorporated into oligonucleotides using conventional or automated oligonucleotide synthetic techniques.
    Type: Grant
    Filed: October 26, 2000
    Date of Patent: March 11, 2003
    Assignee: Serologicals, Inc.
    Inventors: Glenn Nardone, Irena Nazarenko, Jila Boal
  • Patent number: 6117986
    Abstract: Compounds are described comprising pyrimidines substituted at the C-5 position with a linker and quencher. These compounds when incorporated into hairpin oligonucleotides quench the fluorescence of fluorophores linked to the 5'-terminus of the oligonucleotide. These nucleotide-quencher compounds are also easy to incorporate into oligonucleotides using conventional, automated, oligonucleotide synthetic techniques.
    Type: Grant
    Filed: June 10, 1998
    Date of Patent: September 12, 2000
    Assignee: Intergen Company, L.P.
    Inventors: Glenn Nardone, Irena Nazarenko, Jila Boal